A new UCL spin-out company – Autolus – is being launched today to develop and commercialise a new generation of engineered T-cell therapies for haematological and solid tumours, with the backing of £30m in investment from healthcare investment company Syncona.
Entrepreneurship Guest Lecture Series
Publication date: Feb 06, 2013 08:00 AM
Start: Feb 07, 2013 05:15 PM
Christopher Lewis - Founder of Shift Swap
Each year, UCL's Department of Management Science and Innovation and UCL Advances organises a series of guest lectures from leading entrepreneurs and investors.